With the proliferation of multi-site neuroimaging studies, there is a greater need for handling
non-biological variance introduced by differences in MRI scanners and acquisition protocols…

Importance Plasma neurofilament light (NfL) has been suggested as a noninvasive
biomarker to monitor neurodegeneration in Alzheimer disease (AD), but studies are lacking. …

A combination of plasma phospho-tau (P-tau) and other accessible biomarkers might provide
accurate prediction about the risk of developing Alzheimer’s disease (AD) dementia. We …

Plasma biomarkers of amyloid, tau, and neurodegeneration (ATN) need to be characterized
in cognitively unimpaired (CU) elderly individuals. We therefore tested if plasma …

Plasma levels of tau phosphorylated at threonine-217 (p-tau217) is a candidate tool to
monitor Alzheimer’s disease. We studied 150 cognitively unimpaired participants and 100 …

We developed models for individualized risk prediction of cognitive decline in mild cognitive
impairment (MCI) using plasma biomarkers of β-amyloid (Aβ), tau and neurodegeneration. …

Importance There is currently no consensus as to which biomarkers best predict longitudinal
tau accumulation at different clinical stages of Alzheimer disease (AD). Objective To …

Importance Neuronal and axonal destruction are hallmarks of neurodegenerative diseases,
but it is difficult to estimate the extent and progress of the damage in the disease process. …

Cost-effective strategies for identifying amyloid-β (Aβ) positivity in patients with cognitive
impairment are urgently needed with recent approvals of anti-Aβ immunotherapies for Alzheimer…

The Advanced Normalizations Tools ecosystem, known as ANTsX, consists of multiple open-source
software libraries which house top-performing algorithms used worldwide by …